BeyondSpring

-$0.42 (-9.46%) Today
+$0.06 (+1.49%) As of 1:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BeyondSpring and other ETFs, options, and stocks.

About BYSI

BeyondSpring, Inc. engages in the the development and commercialization of immuno-oncology cancer therapies to improve clinical outcomes for patients who have high unmet medical needs. It operates through PRC and U.S. geographical segments.

CEO
Lan Huang
Employees
91
Headquarters
New York, New York
Founded
2013

BYSI Key Statistics

Market cap
157.24M
Price-Earnings ratio
—
Dividend yield
—
Average volume
5.03M
High today
$4.43
Low today
$4.01
Open price
$4.30
Volume
3.10M
52 Week high
$33.00
52 Week low
$3.64

BYSI News

ReutersDec 1

U.S. FDA declines to approve BeyondSpring's neutropenia drug, shares plunge

Dec 1 (Reuters) - BeyondSpring Inc (BYSI.O) said on Wednesday the U.S. Food and Drug Administration (FDA) had declined to approve its drug candidate for prevent

BYSI Earnings

-$0.58
-$0.39
-$0.19
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Dec 14, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure